Digestive & Intestinal Remedies (Pharmacies) - Norway

Revenue in the Digestives & Intestinal Remedies market is projected to reach US$16.63m in 2024.
Revenue is expected to show an annual growth rate (CAGR 2024-2029) of -0.01%, resulting in a market volume of US$16.62m by 2029.
In global comparison, most revenue will be generated China (US$3.37bn in 2024).
In relation to total population figures, per person revenues of US$3.02 are generated in 2024.

Definition:
The Digestives and Intestinal Remedies market encompasses a range of over-the-counter (OTC) natural and synthetic digestive agents and remedies designed to address gastrointestinal concerns. These products are available through pharmacies and are provided in various forms such as pills, powder, capsules, liquids, solutions, suspensions, drops, and suppositories. The market excludes prescription medications, substances contravening state regulations, or items not explicitly categorized as digestive medications (e.g., pain relievers). Notable among the best-selling products in this category are Perenterol, Iberogast, Dulcolax, and Buscopan Plus. This market exclusively covers product sales through pharmacies.

Additional information:
The Digestives and Intestinal Remedies market comprises revenues, average revenue per capita and average revenue per pharmacy. Revenues include VAT. The market only displays B2C revenues, hence B2B and B2G revenues are not included.
For more information on the data displayed, use the info button next to the boxes.

Natural and synthetic agents
Digestive medicines
Remedies against gastrointestinal complaints

Prescription medicines
Homeopathic remedies
Tea

The Digestive & Intestinal Remedies (Pharmacies) market in Norway has been experiencing steady growth in recent years.

Customer preferences: Norwegian consumers have shown a growing interest in natural and herbal remedies for digestive and intestinal issues. This preference for natural products can be attributed to a general trend towards healthier lifestyles and a desire to avoid synthetic chemicals. As a result, there has been an increase in demand for products that are made from natural ingredients and have minimal side effects.

Trends in the market: One of the key trends in the Digestive & Intestinal Remedies market in Norway is the rise of probiotic products. Probiotics are live bacteria and yeasts that are beneficial for gut health. They are believed to improve digestion and boost the immune system. Probiotic supplements and yogurts have gained popularity among Norwegian consumers who are looking for natural ways to improve their digestive health. Another trend in the market is the increasing availability of over-the-counter (OTC) remedies for digestive and intestinal issues. Previously, many of these products required a prescription, but now they are readily available in pharmacies without the need for a doctor's visit. This has made it easier for consumers to access the remedies they need and has contributed to the growth of the market.

Local special circumstances: Norway has a high prevalence of digestive and intestinal issues, which has contributed to the growth of the market. Factors such as a high-fat diet, stress, and sedentary lifestyles have led to an increase in conditions such as indigestion, constipation, and irritable bowel syndrome. As a result, there is a strong demand for remedies that can alleviate these symptoms and improve overall digestive health.

Underlying macroeconomic factors: The growing market for Digestive & Intestinal Remedies in Norway can also be attributed to the country's strong economy and high disposable income levels. Norwegians are willing to spend more on their health and are increasingly seeking out products that can improve their quality of life. This has created a favorable environment for the growth of the market. In conclusion, the Digestive & Intestinal Remedies (Pharmacies) market in Norway is experiencing steady growth due to customer preferences for natural remedies, the rise of probiotic products, the increasing availability of OTC remedies, the high prevalence of digestive and intestinal issues, and the country's strong economy and high disposable income levels.

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

The global online pharmacy sector was estimated at 32 billion U.S. dollars by the end of 2023. In the United States, forecasts indicate that this figure would reach approximately 5.7 billion, solidifying its position as one of the largest online pharmacy markets. However, China dominates the pharma e-commerce industry worldwide, generating nearly 8.5 billion dollars in revenue. With China at the forefront, it is no wonder digital pharmacies make up the fastest-growing segment in the Asian digital health market.